Lasa Supergenerics Limited (LASA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.005x

Based on the latest financial reports, Lasa Supergenerics Limited (LASA) has a cash flow conversion efficiency ratio of 0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.59 Million ≈ $27.98K USD) by net assets (Rs563.42 Million ≈ $6.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see LASA stock market capitalisation for the company's overall valuation and market capitalisation.

Lasa Supergenerics Limited - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Lasa Supergenerics Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Lasa Supergenerics Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lasa Supergenerics Limited ranked by their cash flow conversion efficiency. Explore LASA cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Summit Minerals Ltd AU:SUM	-0.048x
Mynaric AG XETRA:M0YN	0.271x
Marula Mining PLC F:48U0	N/A
Thrive Tribe Technologies Ltd AU:1TT	-1.889x
CleanCore Solutions Inc. NYSE MKT:ZONE	-0.036x
Copper Search Ltd AU:CUS	-0.939x
Gathid Ltd AU:GTH	-0.431x
GuocoLand (Malaysia) Bhd KLSE:1503	-0.003x

Annual Cash Flow Conversion Efficiency for Lasa Supergenerics Limited (2017–2025)

The table below shows the annual cash flow conversion efficiency of Lasa Supergenerics Limited from 2017 to 2025. View LASA share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs837.13 Million ≈ $9.05 Million	Rs-28.24 Million ≈ $-305.37K	-0.034x	-252.47%
2024-03-31	Rs966.76 Million ≈ $10.46 Million	Rs21.39 Million ≈ $231.29K	0.022x	+115.13%
2023-03-31	Rs1.18 Billion ≈ $12.79 Million	Rs-173.00 Million ≈ $-1.87 Million	-0.146x	-350.68%
2022-03-31	Rs1.58 Billion ≈ $17.07 Million	Rs92.12 Million ≈ $996.20K	0.058x	-77.56%
2021-03-31	Rs1.59 Billion ≈ $17.19 Million	Rs413.10 Million ≈ $4.47 Million	0.260x	+169.95%
2020-03-31	Rs1.41 Billion ≈ $15.30 Million	Rs136.23 Million ≈ $1.47 Million	0.096x	-75.06%
2019-03-31	Rs1.05 Billion ≈ $11.39 Million	Rs406.58 Million ≈ $4.40 Million	0.386x	+12.48%
2018-03-31	Rs1.17 Billion ≈ $12.69 Million	Rs402.80 Million ≈ $4.36 Million	0.343x	+962.97%
2017-03-31	Rs754.94 Million ≈ $8.16 Million	Rs-30.03 Million ≈ $-324.76K	-0.040x	--

About Lasa Supergenerics Limited

NSE:LASA India Drug Manufacturers - Specialty & Generic

Market Cap

$3.36 Million

Rs310.63 Million INR

Market Cap Rank

#29372 Global

#1632 in India

Share Price

Rs6.20

Change (1 day)

-4.91%

52-Week Range

Rs5.67 - Rs12.53

All Time High

Rs206.80